Aripiprazole/Sertraline Combination: Clinical and Cost‐Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)—Protocol for a Nested Qualitative Study

Aripiprazole/Sertraline Combination: Clinical and Cost‐Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)—Protocol for a Nested Qualitative Study

ABSTRACT Introduction Bipolar disorder is a recurrent mental health disorder with a prevalence rate of 1.4%. On average, there can be a delay of 9.5 years from the initial presentation of symptoms to a confirmed diagnosis. Individuals living with bipolar disorder have a reduced life expectancy. Ther...

Full description

Saved in:
Bibliographic Details
Main Authors: Isobel Hoppe, Stuart Watson, Caroline Kemp, Fiona Turnbull, Firoza Davies, John Gibson, Lumbini Azim, Lauren Wall, Niraj Ahuja, Sarah Al‐Ashmori, Sally Keys, Thomas Kabir, Carolyn A. Chew‐Graham
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Health Expectations
Subjects:
bipolar depression
bipolar disorder
clinical trial
mental health
nested qualitative study
patient and public involvement
Online Access:https://doi.org/10.1111/hex.70018
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1111/hex.70018

Similar Items